Systematic review / meta-analysis / 2015
Quinine reduces muscle cramp frequency and intensity compared to placebo, but increases minor adverse events.
A systematic review analyzed 23 randomized controlled trials (n = 1,586) evaluating quinine (commonly 300 mg/day) compared to placebo, vitamin E, or other combinations for muscle cramps. Compared to placebo, quinine significantly reduced cramp number over two weeks by 28%, cramp intensity by 10%, and cramp days by 20%, without significantly affecting cramp duration. Minor adverse events, mainly gastrointestinal symptoms, were significantly higher with quinine (risk difference 3%, 95% CI 0% to 6%), while major adverse events showed no significant difference compared to placebo. No significant differences across all outcomes were found when comparing quinine to vitamin E alone or a quinine-vitamin E combination.
- Study type
- Systematic review and meta-analysis of RCTs
- Who was studied
- 1,586 participants across 23 trials with muscle cramps
- What was measured
- Cramp number, intensity, days, duration, and adverse events
THE PAPER
Quinine for muscle cramps.
El-Tawil S, Al Musa T, Valli H, Lunn MP, Brassington R, El-Tawil T, Weber M. Cochrane Database Syst Rev, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.